Learn more about....
*Humanisation of animal models
*Animal models for affective disorders
*Knockout models for parkinsons disease
*New models for age related disease
*Reviewing advances in in-vivo oncology studies
Those who attended previously include:
Failure to accurately predict outcome in the clinic in animal models can result in dramatic costs and slower drug development for the industry. Increasing the translationability and validation of animal models is essential to ensure successful drug development.Download an agenda to see how this meeting can help select the most efficient model for your research programme. Click here for the agenda.
Pre Conference Workshop: 18th June 2012
A Minipig Masterclass: Effectively Selecting your Non-Rodent Species for Pre-Clinical Safety Evaluations
For two reasons the minipig moves into the limelight of non-rodent species selection: Most importantly, with the minipig there is one more species physiologically close to humans to choose from, accomodating the moral imperative to make science-based species selection. This will favour valid results and serve animal welfare (refinement) as well as enhace human drug safety (cf. Guideline CPMP/SWP/1042/99). Secondly, the new EU animal welfare directive (2010/63/EU) encourages the search for alternative species to the reduce the number of non-human primates used. This workshop aims at the introduction of minipigs as an alternative non-rodent species.
Host: Peter Clausing, JP Berlin, Germany
"Useful mixture of topics on current and future animal models, their role in therapeutical research, and some interesting case studies"
"An interesting and informative conference reviewing current techniques and enhancements in preclinical animal models"